America, we are coming!
BSI CTMS launch in the USA
The new year is all about America: The positive response to our latest BSI CTMS release “Denim” has encouraged us to present our successful solution for clinical trial management, or CTMS for short, at the SCOPE Summit in Orlando for the first time.
SCOPE is considered to be one of the premier clinical conferences, attracting more than 1,400 clinical operations managers from all over America. Pharmaceutical companies, pharma sponsors and CROs will inspire each other during keynote lectures, breakout sessions and theme-specific tracks in beautiful Orlando, Florida from February 12 to 15,2018. In addition, the most innovative solutions for planning, managing and conducting clinical trials will be presented.
It is a great pleasure and honor for us to introduce our latest CTMS generation in this dynamic environment. Those who cannot come to Florida will find the XTalks webinar on January 22,2018 an ideal opportunity to secure their CTMS evaluation know-how. The conference will also be archived for future viewing opportunities.
XTalk Webinar on 22 January 2018 and SCOPE Congress in Orlando from 12 to 15 February 2018
At the SCOPE in Orlando, Jens B. Thuesen will share his many years of experience in implementing CTMS solutions and will provide insight into what to look for when evaluating a CTMS partner. “Choosing the Right CTMS for Your Clinical Trial Using a 4-Step Evaluation Process" is also the title of the XTalks webinar on 22 January 2018, in which Jens, Jan Nielsen and Stefan Vogt, our CTMS experts at BSI, will inform the audience about the modern way of evaluating CTMS software.
We are very much looking forward to the two events. We hope that we will also inspire many American clinical operations professionals to partner with BSI and discover why so many clinical customers here in Europe, including well-known companies such as Actelion, ALK-Abelló, Allergopharma, Dokumeds and a well-known Fortune 500 company trust BSI software to help them to keep their clinical trials optimized and on track, every day.